Article Details

Roche walks away from 4DMT's eye gene therapy before early-stage trial finishes

Retrieved on: 2021-06-24 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Roche walks away from 4DMT's eye gene therapy before early-stage trial finishes. View article details on hiswai:

Excerpt

Effective September 16, Roche will terminate its collaboration with 4D Molecular Therapeutics on an eye disease treatment, leaving the small biotech ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up